Critsal Inhaler combines Levosalbutamol and Ipratropium, two effective bronchodilators used for the treatment of chronic respiratory conditions such as Asthma and Chronic Obstructive Pulmonary Disease (COPD). This inhaler works by delivering the medication directly to the lungs, where it can quickly relieve symptoms of bronchospasm, improve airflow, and make breathing easier.
Levosalbutamol is a selective beta-2 agonist that helps relax the smooth muscles around the airways, allowing the airways to open up and reduce wheezing, coughing, and shortness of breath. Ipratropium, an anticholinergic agent, blocks the action of acetylcholine, a chemical that can cause constriction of the airways, thus further enhancing bronchodilation.
This combination of two medications in Critsil Inhaler provides fast relief from symptoms such as chest tightness, wheezing, and shortness of breath. The inhaler is designed for quick and effective delivery of medication to the lungs, offering immediate relief in cases of acute bronchospasm and aiding in long-term management of asthma and COPD.